Clinical Trial: A Study of XmAb23104 in People With Sarcoma
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: Sarcoma
Study Type: INTERVENTIONAL
Official Title: Phase II Study of XmAb23104 (Targeting PD-1 and ICOS), in Patients With Advanced Sarcoma
Brief Summary:
The purpose of this study is to find out whether the study drug, XmAb23104, is an effective treatment for advanced sarcoma.The researchers will also look at whether XmAb23104 is safe and causes few or mild side effects in participants.
Read more